NO20000098D0 - Anvendelse av hyaluronidase ved fremstillingen av et medikament for behandling av inflammasjon - Google Patents

Anvendelse av hyaluronidase ved fremstillingen av et medikament for behandling av inflammasjon

Info

Publication number: NO20000098D0
Authority: NO; Norway
Prior art keywords: hyaluronidase; treatment; inflammation; medicament; manufacture
Prior art date: 1997-07-09

Application number

NO20000098A

Other languages

English (en)

Norwegian (no)

Other versions

NO20000098L (no

Inventor

Cecilia Johnsson

Gunnar Tufveson

Roger Hollgren

Bengt Gerdin

Original Assignee

Cecilia Johnsson

Gunnar Tufveson

Roger Hollgren

Bengt Gerdin

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-09

Filing date

2000-01-07

Publication date

2000-01-07

2000-01-07 Application filed by Cecilia Johnsson, Gunnar Tufveson, Roger Hollgren, Bengt Gerdin filed Critical Cecilia Johnsson

2000-01-07 Publication of NO20000098L publication Critical patent/NO20000098L/no

2000-01-07 Publication of NO20000098D0 publication Critical patent/NO20000098D0/no

Links

108010003272 Hyaluronate lyase Proteins 0.000 title abstract 3
102000001974 Hyaluronidases Human genes 0.000 title abstract 3
229960002773 hyaluronidase Drugs 0.000 title abstract 3
206010061218 Inflammation Diseases 0.000 title abstract 2
230000004054 inflammatory process Effects 0.000 title abstract 2
239000003814 drug Substances 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
241000124008 Mammalia Species 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 abstract 1
229940099552 hyaluronan Drugs 0.000 abstract 1
229920002674 hyaluronan Polymers 0.000 abstract 1
230000008595 infiltration Effects 0.000 abstract 1
238000001764 infiltration Methods 0.000 abstract 1
210000004969 inflammatory cell Anatomy 0.000 abstract 1
210000000056 organ Anatomy 0.000 abstract 1
238000003786 synthesis reaction Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Transplantation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Enzymes And Modification Thereof (AREA)
Medicines Containing Plant Substances (AREA)

NO20000098A 1997-07-09 2000-01-07 Anvendelse av hyaluronidase ved fremstillingen av et medikament for behandling av inflammasjon NO20000098D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9702657A SE512633C2 (sv)	1997-07-09	1997-07-09	Användning av hyaluronidas för reduktion av inflammatoriska cellinfiltrat
PCT/SE1998/000831 WO1999002181A1 (en)	1997-07-09	1998-05-06	Use of hyaluronidase in the manufacturing of a drug for the treatment of inflammation

Publications (2)

Publication Number	Publication Date
NO20000098L NO20000098L (no)	2000-01-07
NO20000098D0 true NO20000098D0 (no)	2000-01-07

Family

ID=20407703

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20000098A NO20000098D0 (no)	1997-07-09	2000-01-07	Anvendelse av hyaluronidase ved fremstillingen av et medikament for behandling av inflammasjon

Country Status (11)

Country	Link
US (1)	US6572855B1 (de)
EP (1)	EP0994719B1 (de)
JP (1)	JP2002509542A (de)
AT (1)	ATE332706T1 (de)
AU (1)	AU741770B2 (de)
CA (1)	CA2296581A1 (de)
DE (1)	DE69835210T2 (de)
ES (1)	ES2267186T3 (de)
NO (1)	NO20000098D0 (de)
SE (1)	SE512633C2 (de)
WO (1)	WO1999002181A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10026666A1 (de) *	2000-05-29	2001-12-20	Gunther Burgard	Verwendung von Hyaluronidase zur Prophylaxe und Behandlung von Herz-Kreislauf-Erkrankungen
US6682904B1 (en) *	2002-08-15	2004-01-27	Deliatroph Pharmaceuticals, Inc.	Specific inhibitors of hyaluronidase 2, and methods of identifying and using same
NZ542873A (en)	2003-03-05	2008-07-31	Halozyme Inc	Soluble, neutral-active hyaluronidase activity glycoprotein (sHASEGP) that is produced with high yield in a mammalian expression system by introducing nucleic acids that lack a narrow region encoding amino acids in the carboxy terminus of the human PH20 cDNA
WO2008149428A1 (ja) *	2007-06-05	2008-12-11	Glycoscience Laboratories, Inc.	自己免疫疾患、炎症及び神経疾患の治療剤及び予防剤
KR20130116386A (ko)	2008-04-14	2013-10-23	할로자임, 아이엔씨	히알루로난 관련 질환 및 상태 치료용 변형된 히알루로니다제 및 그 용도
US8685462B1 (en)	2012-09-17	2014-04-01	Biopep Solutions, Inc.	Whole, leech saliva product and applications thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8504025D0 (en) *	1985-02-16	1985-03-20	Biopharm Ltd	Hyaluronidase
US5747027A (en) *	1995-04-07	1998-05-05	The Regents Of The University Of California	BH55 hyaluronidase
US5958750A (en)	1996-07-03	1999-09-28	Inctye Pharmaceuticals, Inc.	Human hyaluronidase

1997
- 1997-07-09 SE SE9702657A patent/SE512633C2/sv not_active IP Right Cessation
1998
- 1998-05-06 AU AU74618/98A patent/AU741770B2/en not_active Ceased
- 1998-05-06 CA CA002296581A patent/CA2296581A1/en not_active Abandoned
- 1998-05-06 WO PCT/SE1998/000831 patent/WO1999002181A1/en not_active Ceased
- 1998-05-06 ES ES98921978T patent/ES2267186T3/es not_active Expired - Lifetime
- 1998-05-06 AT AT98921978T patent/ATE332706T1/de not_active IP Right Cessation
- 1998-05-06 JP JP50850999A patent/JP2002509542A/ja active Pending
- 1998-05-06 EP EP98921978A patent/EP0994719B1/de not_active Expired - Lifetime
- 1998-05-06 US US09/462,362 patent/US6572855B1/en not_active Expired - Fee Related
- 1998-05-06 DE DE69835210T patent/DE69835210T2/de not_active Expired - Lifetime
2000
- 2000-01-07 NO NO20000098A patent/NO20000098D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU7461898A (en)	1999-02-08
SE9702657L (sv)	1999-01-10
SE9702657D0 (sv)	1997-07-09
WO1999002181A1 (en)	1999-01-21
NO20000098L (no)	2000-01-07
US6572855B1 (en)	2003-06-03
JP2002509542A (ja)	2002-03-26
DE69835210T2 (de)	2007-07-05
AU741770B2 (en)	2001-12-06
SE512633C2 (sv)	2000-04-17
EP0994719B1 (de)	2006-07-12
DE69835210D1 (de)	2006-08-24
CA2296581A1 (en)	1999-01-21
ES2267186T3 (es)	2007-03-01
EP0994719A1 (de)	2000-04-26
ATE332706T1 (de)	2006-08-15

Similar Documents

Publication	Publication Date	Title
NO995095D0 (no)	1999-10-19	Substituerte imidazoler nyttig ved behandlingen av inflammasjonssykdommer
BR9916746A (pt)	2005-01-11	Compostos anti-inflamatórios que inibem adesão de célula
CA2105529A1 (en)	1994-03-05	Composition comprising non-steroidal anti-inflammatory agent and effectively non-antibacterial tetracycline
PT966447E (pt)	2003-07-31	Moleculas pequenas uteis no tratamento de doencas inflamatorias
TR200200160T2 (tr)	2002-10-21	Antiinflamatuar ajanlar olarak imidazoller ve triazoller
AR009560A1 (es)	2000-04-26	Prolongacion de la sobrevida de injertos con porfirinas
GB9807639D0 (en)	1998-06-10	Anti-inflammatory agents
PT1131039E (pt)	2005-11-30	Utilizacao de uma substancia que se liga ao receptor periferico das benzodiazepinas no tratamento de stresses cutaneos
DK0813417T3 (da)	2003-11-03	Anvendelse af hyaluronsyre til behandling af betændelse i blæreslimhinden
TR199800415T1 (en)	1998-05-21	Farmas�tik form�lasyon.
DE69826684D1 (de)	2004-11-04	Kovalent gebundenes n,o-carboxymethylchitosan und seine verwendungen
NO20056021L (no)	1999-03-15	Anvendelse av CS-866 til fremstilling av et medikament
AU5045690A (en)	1990-08-24	Composition and method for treating benign prostatic hypertrophy
DK0869965T3 (da)	2000-10-16	Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler
NO20000098L (no)	2000-01-07	Anvendelse av hyaluronidase ved fremstillingen av et medikament for behandling av inflammasjon
NO20002827L (no)	2000-06-02	Anvendelse av fosfolipidkomplekser av Vitis vinifera som antiaterosklerotiske midler
DK1124566T3 (da)	2003-06-02	Ikke-fermenteret osmotisk laxativ til behandling og forebyggelse af colorectale cancere
AU2001293707A1 (en)	2002-02-18	Anti-inflammatory medicament
ES2176435T3 (es)	2002-12-01	Procedimiento para mejorar la actividad terapeutica de medicamentos anti-inflamatorios (nsaids) y composicion de fosfolipidos dipolares utiles para tales fines.
TR199900662T2 (xx)	1999-06-21	1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m�
ES2181915T3 (es)	2003-03-01	Ctla-8 en combinacionpn con g-csf y il-6, y uso de ctla-8 para tratar infecciones.
SE9504267D0 (sv)	1995-11-29	New therapeutic use
NO990898D0 (no)	1999-02-25	Anvendelse av hyaluronidase
NO980289D0 (no)	1998-01-22	Bowman-Birk inhibitor sammensetninger for behandling av inflammatorisk sykdom
ES2161293T3 (es)	2001-12-01	Derivados de enol acilados como profarmacos de inhibidores de la elastasa.

Legal Events

Date	Code	Title	Description
2008-01-14	FC2A	Withdrawal, rejection or dismissal of laid open patent application